MDXG
Mimedx Group Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.
Market Cap: 1.19 Billion
Primary Exchange: NASDAQ
Website: mimedx.com
Shares Outstanding: 147 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.9602522872496121
Sector: Manufacturing
Industry: Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Ethical Flags
Longest drawdown: 1278 trading days
From: 2018-01-29 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|